
Wolverine peptide is the most-searched recovery stack in the research space, and also the most inconsistently sold. The name is a nickname, not a specification. One supplier’s Wolverine peptide is two separate vials, another’s is a single co-lyophilized vial, and a third’s is a three-compound bundle with a different ratio again. That is why “where to buy Wolverine peptide” is a harder question than it looks: the label tells you almost nothing until you open the certificate.
This guide answers it directly. It covers what a genuine Wolverine peptide vial contains, blend versus stack, the protocols that circulate in the research community, how to vet a Wolverine peptide supplier, and the one source we recommend in 2026.
Where to Buy Wolverine Peptide Stack: The Short Answer
The supplier we recommend for Wolverine peptide in 2026 is HEEZ Research. It clears every check we apply to a Wolverine peptide listing, and it is the only supplier we reviewed that does all of the following on a single product page:
- Per-component third-party COA, published on the page. Each peptide in the Wolverine blend is synthesized and purified independently, then co-lyophilized at the stated ratio. The lot is analysed by HPLC for purity and mass spectrometry for identity, with results reported per component, and the certificate is published on the listing rather than “available on request.” Purity is stated as greater than 99% per component.
- Stated split. 5 mg + 5 mg, 10 mg total, printed on the listing. No “proprietary blend,” no unstated ratio.
- Sealed lyophilized vial. Stable at ambient temperature in transit; ships without cold packaging.
- Same-day domestic dispatch. Orders placed before 3 PM ET ship the same day via UPS 2nd Day Air or Overnight, in discreet packaging, from within the USA.
- Strict research-use positioning. Every listing on HEEZ Research is labelled for in-vitro laboratory research only, purchasers must be 21 or older and affiliated with a research organisation, and the site carries no treatment claims.
- Individual vials available. The two component peptides are also stocked separately for protocols that need the ratio changed.
The Wolverine peptide blend at HEEZ Research is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
The rest of this article explains why those checks matter and how to apply them to any other Wolverine peptide source.
What Is Wolverine Peptide?
Wolverine peptide is not a new molecule. It is a co-formulated pairing of two existing regenerative peptides, BPC-157 and TB-500, named after the comic-book character who heals from anything. The two are combined because they are associated with different stages of the tissue-repair cascade:
- The first component (a 15-amino-acid gastric-derived peptide) is associated with the signalling that initiates and organises repair: growth-factor upregulation, nitric-oxide regulation, fibroblast migration and tendon outgrowth in animal and explant models.
- The second (a synthetic fragment of thymosin beta-4, a 43-amino-acid actin-binding protein) operates at the physical mechanics of cell movement: sequestering G-actin so cells can build the cytoskeleton needed to migrate into a wound bed.
One directs the response; the other carries it out. That division of labour is the entire rationale for the Wolverine peptide, and it is inferred from the individual mechanisms rather than demonstrated in a head-to-head trial. No controlled study of the combination has been published.
You will see the same pairing described as the Wolverine peptide, Wolverine blend, Wolverine stack and Wolverine protocol. “Blend” usually means one vial; “stack” can mean two vials run together. Suppliers use the terms loosely.
Wolverine Peptide Blend vs Wolverine Stack
This is the first decision when buying Wolverine peptide, and it changes what the certificate can tell you.
| Factor | Wolverine blend (one vial) | Wolverine stack (two vials) |
| Reconstitution | Once | Twice |
| Ratio | Fixed by the supplier | Set by the researcher |
| COA | Should report each component separately; many suppliers give one averaged figure | One certificate per vial |
| Storage | One vial to refrigerate after reconstitution | Two |
| Typical use | Standard 1:1 protocols | Front-loaded or single-component phases |
Choose the Wolverine blend when the protocol keeps the two components at roughly equal mass (the standard 250/250 or 500/500 mcg pattern), and one reconstitution instead of two matters.
Choose the Wolverine stack when the protocol front-loads the second component well above the first, or only one component is needed for a given phase.
The blend’s one weakness — a single averaged purity number — disappears when the supplier reports each component separately, which is why per-component testing is the first thing to check on any Wolverine peptide listing.
Wolverine Peptide Dosage Reported in the Research Community
The following describes protocols that circulate in research and performance communities. It is informational context only, not medical advice, and does not describe the intended use of any research-grade product referenced in this article.
Because a Wolverine peptide blend is locked at a fixed ratio, one component drives the dose and the other rides along. In practice the 15-amino-acid component’s target drives it.
| Component | Commonly reported range | Frequency | Typical duration |
| Component 1 (BPC-157) | 250–500 mcg | Once or twice daily | 4–8 weeks |
| Component 2 (TB-500) | 2–5 mg per week loading; 2–5 mg per month maintenance | Split into 2 doses per week | 4–6 weeks loading |
With a 1:1 Wolverine peptide, a daily 250 mcg draw of the first component delivers 250 mcg of the second at the same time — roughly 1.75 mg per week, inside the reported loading range without a second vial.
Reconstitution math for a 5 mg + 5 mg Wolverine peptide vial. Adding 2 mL of bacteriostatic water yields 2.5 mg/mL of each component. On a U-100 insulin syringe:
| Draw | Volume | Component 1 delivered | Component 2 delivered |
| 10 units | 0.10 mL | 250 mcg | 250 mcg |
| 20 units | 0.20 mL | 500 mcg | 500 mcg |
| 40 units | 0.40 mL | 1,000 mcg | 1,000 mcg |
At 10 units per day a 5 mg + 5 mg Wolverine peptide vial lasts 20 days; at 20 units per day, 10 days. Community-reported administration is subcutaneous, near the affected area or in the abdomen, with reconstituted vials refrigerated at 2–8 °C and used within roughly four weeks.
Wolverine Peptide Side Effects and Cautions
There is no safety trial for Wolverine peptide, and tolerability data for the individual components comes from animal studies and informal reports. Commonly reported subjective effects include:
- Redness, itching or a small welt at the injection site
- Mild nausea or headache in the first week
- Transient fatigue or light-headedness
- Rare reports of dizziness or flushing
Two structural cautions matter more than the anecdotal effects:
- Angiogenesis. Both components are studied precisely because they promote new blood-vessel growth and cell migration — desirable in a healing tendon, theoretically undesirable near an undiagnosed tumour. This caveat recurs in the thymosin beta-4 literature.
- Regulatory status. Neither component of Wolverine peptide is FDA-approved for any indication. Both sit in the withdrawn section of the FDA’s 503A bulk-substances list, and both are prohibited under WADA’s S0 category for tested athletes.
What the Research Actually Shows
Wolverine peptide is often described in language the evidence does not support, so it is worth being precise.
The first component’s evidence base is almost entirely rodent work, much of it from one research group in Zagreb. Within that limit the findings are consistent: faster biomechanical and histological recovery of transected rat Achilles tendon (J Orthop Res, 2003); tendon-fibroblast outgrowth, survival and migration in explant culture (J Appl Physiol, 2011); and restored muscle healing in corticosteroid-impaired rats (Med Sci Monit, 2010). There are no completed peer-reviewed human efficacy trials.
The second component’s parent protein, thymosin beta-4, has a broader literature that includes human data: accelerated dermal wound closure in rat models (J Invest Dermatol, 1999), a regenerative-properties review across cardiac, dermal, corneal and neural models (Expert Opin Biol Ther, 2012), and Phase 2 human trials for dry eye and epidermolysis bullosa. The research-grade fragment sold as TB-500 has thinner direct evidence than the full-length protein.
For the Wolverine peptide combination itself: no controlled study, animal or human. Anyone claiming “clinical proof” for the blend is overstating the data.
How to Vet a Wolverine Peptide Supplier
Wolverine peptide carries a vetting problem single peptides do not: the label claims two things and the certificate has to verify both. Before you buy Wolverine peptide from any source, run these five checks. Each takes under a minute on a product page.
1. Per-component COA, published on the page. A real Wolverine peptide certificate reports HPLC purity and mass-spec identity for each component separately, not one aggregate figure. “COA available on request” is a weaker signal than a certificate you can open before ordering.
2. Stated ratio. The mass of each component should be printed on the listing. “10 mg blend” says nothing about the split.
3. Independent testing. The lab performing the analysis should be outside the seller’s building. In-house purity claims are not verification.
4. Lyophilized, sealed vials. Lyophilized powder is stable at ambient temperature in transit; pre-mixed liquid is not.
5. Research-use compliance. A legitimate Wolverine peptide supplier states unambiguously that the material is for in-vitro laboratory use, requires purchasers to be qualified researchers, and makes no health claims. Suppliers selling Wolverine peptide with treatment language are the ones most likely to ship underdosed or unverified material.
HEEZ Research passes all five, which is the basis for the recommendation above. The Wolverine blend for sale there is the format we would default to for any standard 1:1 protocol.
Is Wolverine Peptide Legal?
Selling Wolverine peptide as labelled research material is legal in the United States. Selling it for human use is not, and neither component is an approved drug. Both appear in the nominated-but-withdrawn section of the FDA’s 503A bulk-substances list, both are banned in tested sport under WADA rules, and state rules on research peptides are changing. Availability online is not approval.
Frequently Asked Questions
Where can I buy Wolverine peptide?
From a specialist research-peptide supplier that ships domestically and publishes a per-component certificate on the product page. HEEZ Research is our recommendation for 2026. Skip general marketplaces, where listings rarely carry a lot number you can match to the vial.
What is in Wolverine peptide?
Two peptides: BPC-157 and TB-500, co-lyophilized in one vial. Most research-grade versions use a 1:1 ratio, commonly 5 mg of each for 10 mg total.
Is Wolverine peptide the same as the Wolverine stack?
Same pairing, different format. “Blend” usually means one co-lyophilized vial at a fixed ratio; “stack” can mean two separate vials run together.
How long does a 5 mg + 5 mg Wolverine peptide vial last?
Twenty days at 250 mcg per component per day; ten days at 500 mcg.
How should Wolverine peptide be stored?
Sealed lyophilized vials are stable at room temperature in transit and should be kept sealed and out of light until use. Once reconstituted with bacteriostatic water, refrigerate at 2–8 °C.
Does Wolverine peptide come with a COA?
From a credible supplier, yes — and the format matters. Look for a certificate that reports each component separately rather than one averaged purity figure.
Is there human clinical data on Wolverine peptide?
No. The individual components have rodent data and, for the second component’s parent protein, some human trial data. The combination has never been tested in a controlled trial.
Is Wolverine peptide FDA-approved?
No. Neither component is an approved drug, and no certificate changes that. A COA proves what is in the vial; approval travels with the compound, not the vendor.
References
- Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976–983.
- Chang CH, et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011;110(3):774–780.
- Pevec D, et al. Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application. Med Sci Monit. 2010;16(3):BR81–88.
- Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364–368.
- Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37–51.
This article is for informational purposes only and does not constitute medical advice. The compounds discussed are not approved by the FDA for any use. Research-grade products referenced here are sold for in-vitro laboratory research only.
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
